REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
USD 7.53 billion by 2030 | 13.1% | North America |
by Product | by Application | by End User | by Region |
---|---|---|---|
|
|
|
|
SCOPE OF THE REPORT
Oligonucleotide Synthesis Market Overview
The oligonucleotide synthesis market is expected to grow at 13.1% CAGR from 2023 to 2030. It is expected to reach above USD 7.53 billion by 2030 from USD 3.18 billion in 2023.
The creation of oligonucleotides is the chemical synthesis of relatively short nucleic acid fragments having a known chemical structure (sequence). The method is very helpful in modern laboratory practice since it offers quick and affordable access to specially manufactured oligonucleotides with the necessary sequence. It is helpful for performing molecular diagnoses for a few illnesses, including the identification of infectious diseases like hepatitis and SARS-COV2 as well as the diagnosis of cancer. One of the main factors propelling the growth of the oligonucleotide synthesis market is the rise in government support for synthetic biology and genome projects as well as active research. The market’s expansion is additionally fueled by R&D investments made by pharmaceutical and biotechnology firms to create oligonucleotide solutions with improved therapeutic potential and fewer adverse effects.
In addition, the increasing use of synthesized oligonucleotides in molecular diagnostics and therapeutic applications, as well as the rise in demand for high-end customized oligos and improvements in the purification of synthetic oligonucleotides, all contribute to the market’s expansion. Contrarily, the complexity of therapeutic oligos and the difficulty of delivering oligonucleotide medications to specific targets may impede the market for oligonucleotide production. However, development prospects in developing nations and a growing interest in personalized treatment are expected to open attractive business potential.
In biological and forensic applications like as research, disease diagnostics, and therapies, oligonucleotides are primarily used. Natural oligonucleotides have been widely employed for site-directed mutagenesis, hybridization probes or affinity purification, gene assembly, and selection and determination of DNA sequences. Additionally, for diagnostic purposes, they are utilized to block gene expression in in-vitro research. The demand for technological advancements in synthetic chemistry has increased due to the increased use of oligonucleotides. Thus, the development of more modern and sophisticated techniques is being undertaken by numerous biotechnology and pharmaceutical companies.
Workflows in the global healthcare industry have been impacted by the COVID-19 epidemic. Several sectors, including numerous branches of healthcare, have been forced to temporarily close their doors due to the disease. Although there has been a negative impact, there has also been a rise in demand for oligonucleotide products and other medical services. The creation of test kits, medication, and vaccinations that are intended to combat the new Coronavirus illness is dependent on oligo products. Additionally, new generations of oligonucleotide medications, including mRNA and DNA vaccines, are now being developed in response to the rise in instances of coronavirus illness (COVID-19) and the need for a viable treatment. Imperial College London (UK) and Biotechnologies (a division of Maravai Lifesciences) have partnered to produce self-amplifying RNA for the creation of a COVID-19 vaccine. Furthermore, during the COVID-19 pandemic, Biolegio B.V. (Netherlands) quickly expanded its production capacities to produce primers and probes for RT-qPCR testing of the Coronavirus and has been providing labs and clients with enough primer and probe sets to run millions of tests.
ATTRIBUTE | DETAILS |
Study period | 2020-2030 |
Base year | 2022 |
Estimated year | 2023 |
Forecasted year | 2023-2030 |
Historical period | 2019-2021 |
Unit | Value (USD Billion) |
Segmentation | Â By Product, By Application, By End User, By Region |
By Product  |
|
By Application  |
|
By End User  |
|
By Region  |
|
Oligonucleotide Synthesis Market Segment Analysis
The oligonucleotide synthesis market is segmented based on product, application, end user, and region.
By product the market is segmented into oligonucleotide-based drugs, synthesized oligonucleotides, reagents, equipment. A significant portion of the market made up of oligonucleotide-based drugs. The goal of oligonucleotide-based medications is to treat a variety of diseases, including cancer, genetic problems, and infectious diseases. These drugs are made of synthetic DNA or RNA molecules that are made to target particular genes or proteins in the body. The manufacturing of vast amounts of high-quality oligonucleotides with certain sequences and alterations has been made possible by developments in oligonucleotide synthesis technology, which has helped the creation of oligonucleotide-based pharmaceuticals.
By application the market is segmented into therapeutic applications, research applications, diagnostic applications. A significant portion of the market made up of therapeutic applications. Oligonucleotides are being employed more frequently as therapies to treat a wide range of illnesses, such as cancer, viral infections, inflammatory diseases, genetic disorders, and cancer. The capacity of oligonucleotides to target genes or proteins makes them highly selective and efficient treatments for treating conditions with complicated genetic and molecular underpinnings. Oligonucleotide-based treatments offer a wide range of therapeutic options since they may be created to target many RNA molecule types, such as messenger RNA (mRNA), microRNA (miRNA), and long non-coding RNA (lncRNA).
By end user the market is segmented into hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, academic research institutes. A significant portion of the market made up of pharmaceutical & biotechnology companies. These businesses are engaged in oligonucleotide-based therapeutic applications research and development, as well as the development of new medications and diagnostic tools. Many different applications, including target validation, lead discovery and optimization, and preclinical development, call for the usage of oligonucleotides in pharmaceutical and biotechnology research. A number of factors, such as rising oligonucleotide therapeutics research and development activities, rising investments in personalized medicine and targeted therapies, and the rising incidence of chronic diseases, all of which are expected to contribute to the pharmaceutical and biotechnology companies’ segment of the oligonucleotide synthesis market’s continued growth.
Oligonucleotide Synthesis Market Key Players
The oligonucleotide synthesis market key players include Thermo Fisher Scientific, Merck KGaA, LGC Limited, Maravai Life Sciences, Alnylam Pharmaceuticals, Inc., Biogen Inc., Danaher Corporation, Eurofins Scientific, Ionis Pharmaceuticals, Inc., Kaneka Corporation.
- On March 2023, Thermo Fisher Scientific, the world leader in serving science, and Arsenal Biosciences, Inc. (ArsenalBio), a clinical-stage cell therapy company engineering advanced chimeric antigen receptor (CAR)-T cell therapies for solid tumors, announced an update to our strategic collaboration to further the development of manufacturing processes for new cancer treatments. This research and process development-focused collaboration has enabled ArsenalBio to developed a robust manufacturing process for their next-generation, programmable autologous T cells for the treatment of cancer.
- On June 2020, OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, announced an exclusive contract with LGC Biosearch Technologies Inc. (LGC), a contract development and manufacturing organization (CDMO) and part of the global life sciences tools company headquartered in London, to scale production of OliX’s OLX301D therapeutic candidate.
Who Should Buy? Or Key Stakeholders
- Healthcare Industry
- Hospitals and Clinics
- Scientific Research and Development
- Investors
- End User Companies
- Government and Regulatory Authorities
- Others
Oligonucleotide Synthesis Market Regional Analysis
The oligonucleotide synthesis market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico, and Rest of North America
- Asia Pacific: includes China, Japan, South Korea, India, Australia, and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina, and Rest of South America
- Middle East & Africa: includes UAE, South Africa, Saudi Arabia, and Rest of MEA
In 2022, North America had a market share of more than 35%, a number of top pharmaceutical and biotechnology companies are in the area, and there is a well-established infrastructure for research and development. The development of the oligonucleotide synthesis industry in North America has also been aided by favourable government initiatives and investments in genomics and personalized medicine.
The demand for personalised treatment and rising investments in life sciences research and development have made Europe the second-largest market for oligonucleotide synthesis. The oligonucleotide synthesis market is anticipated to increase significantly in the Asia-Pacific region as a result of rising biotechnology and pharmaceutical R&D activities, as well as rising government spending on genomics and personalised medicine.
Key Market Segments: Oligonucleotide Synthesis Market
Oligonucleotide Synthesis Market by Product, 2020-2030, (USD Billion)
- Oligonucleotide-Based Drugs
- Synthesized Oligonucleotides
- Reagents
- Equipment
Oligonucleotide Synthesis Market by Application, 2020-2030, (USD Billion)
- Therapeutic Applications
- Research Applications
- Diagnostic Applications
Oligonucleotide Synthesis Market by End User, 2020-2030, (USD Billion)
- Hospitals
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- CROs and CMOs
- Academic Research Institutes
Oligonucleotide Synthesis Market by Region, 2020-2030, (USD Billion)
- North America
- Asia Pacific
- Europe
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered.
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new Application
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the oligonucleotide synthesis market over the next 7 years?
- Who are the major players in the oligonucleotide synthesis market and what is their market share?
- What are the end user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, And Africa?
- How is the economic environment affecting the oligonucleotide synthesis market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the oligonucleotide synthesis market?
- What is the current and forecasted size and growth rate of the global oligonucleotide synthesis market?
- What are the key drivers of growth in the oligonucleotide synthesis market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the oligonucleotide synthesis market?
- What are the technological advancements and innovations in the oligonucleotide synthesis market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the oligonucleotide synthesis market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the oligonucleotide synthesis market?
- What are the product offerings and specifications of leading players in the market?
- What is the pricing trend of oligonucleotide synthesis market in the market and what is the impact of raw material prices on the price trend?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON OLIGONUCLEOTIDE SYNTHESIS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET OUTLOOK
- GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
- OLIGONUCLEOTIDE-BASED DRUGS
- SYNTHESIZED OLIGONUCLEOTIDES
- REAGENTS
- EQUIPMENT
- GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
- THERAPEUTIC APPLICATIONS
- RESEARCH APPLICATIONS
- DIAGNOSTIC APPLICATIONS
- GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
- HOSPITALS
- PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- DIAGNOSTIC LABORATORIES
- CROS AND CMOS
- ACADEMIC RESEARCH INSTITUTES
- GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY REGION (USD BILLION), 2020-2030
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES*
(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- THERMO FISHER SCIENTIFIC
- MERCK KGAA
- LGC LIMITED
- MARAVAI LIFE SCIENCES
- ALNYLAM PHARMACEUTICALS, INC.
- BIOGEN INC.
- DANAHER CORPORATION
- EUROFINS SCIENTIFIC
- IONIS PHARMACEUTICALS, INC.
- KANEKA CORPORATION
*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 2 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 3 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 4 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY REGION (USD BILLION), 2020-2030
TABLE 5 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 6 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 7 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 8 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY COUNTRY (USD BILLION), 2020-2030
TABLE 9 US OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 10 US OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 11 US OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 12 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (BILLION), 2020-2030
TABLE 13 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 14 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 15 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 16 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 17 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 18 REST OF NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 19 REST OF NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 20 REST OF NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 21 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 22 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 23 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 24 SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY COUNTRY (USD BILLION), 2020-2030
TABLE 25 BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 26 BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 27 BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 28 ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 29 ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 30 ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 31 COLOMBIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 32 COLOMBIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 33 COLOMBIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 34 REST OF SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 35 REST OF SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 36 REST OF SOUTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 37 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 38 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 39 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 40 ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET BY COUNTRY (USD BILLION), 2020-2030
TABLE 41 INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 42 INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 43 INDIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 44 CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 45 CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 46 CHINA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 47 JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 48 JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 49 JAPAN OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 50 SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 51 SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 52 SOUTH KOREA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 53 AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 54 AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 55 AUSTRALIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 56 REST OF ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 57 REST OF ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 58 REST OF ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 59 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 60 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 61 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 62 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET BY COUNTRY (USD BILLION), 2020-2030
TABLE 63 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 64 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 65 GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 66 UK OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 67 UK OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 68 UK OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 69 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 70 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 71 FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 72 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 73 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 74 ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 75 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 76 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 77 SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 78 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 79 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 80 RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 81 REST OF EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 82 REST OF EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 83 REST OF EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 84 MIDDLE EAST AND AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 85 MIDDLE EAST AND AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 86 MIDDLE EAST AND AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 87 MIDDLE EAST AND AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY COUNTRY (USD BILLION), 2020-2030
TABLE 88 UAE OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 89 UAE OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 90 UAE OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 91 SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 92 SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 93 SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 94 SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 95 SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 96 SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
TABLE 97 REST OF MIDDLE EAST AND AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT (USD BILLION), 2020-2030
TABLE 98 REST OF MIDDLE EAST AND AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION (USD BILLION), 2020-2030
TABLE 99 REST OF MIDDLE EAST AND AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER (USD BILLION), 2020-2030
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 MARKET SEGMENTATION
FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4 DATA TRIANGULATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 RESEARCH FLOW
FIGURE 8 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT, USD BILLION, 2020-2030
FIGURE 9 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION, USD BILLION, 2020-2030
FIGURE 10 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER, USD BILLION, 2020-2030
FIGURE 11 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET BY REGION, USD BILLION, 2020-2030
FIGURE 12 PORTER’S FIVE FORCES MODEL
FIGURE 13 OLIGONUCLEOTIDE SYNTHESIS MARKET BY REGION 2022
FIGURE 14 OLIGONUCLEOTIDE SYNTHESIS MARKET BY PRODUCT 2022
FIGURE 15 OLIGONUCLEOTIDE SYNTHESIS MARKET BY APPLICATION 2022
FIGURE 16 OLIGONUCLEOTIDE SYNTHESIS MARKET BY END USER 2022
FIGURE 17 MARKET SHARE ANALYSIS
FIGURE 18 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 19 MERCK KGAA: COMPANY SNAPSHOT
FIGURE 20 LGC LIMITED: COMPANY SNAPSHOT
FIGURE 21 MARAVAI LIFE SCIENCES: COMPANY SNAPSHOT
FIGURE 22 ALNYLAM PHARMACEUTICALS, INC.: COMPANY SNAPSHOT
FIGURE 23 BIOGEN INC.: COMPANY SNAPSHOT
FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 25 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 26 IONIS PHARMACEUTICALS, INC.: COMPANY SNAPSHOT
FIGURE 27 KANEKA CORPORATION: COMPANY SNAPSHOT
FAQ
The global oligonucleotide synthesis market revenue is projected to expand at a CAGR of 13.1% during the forecast period.
The global oligonucleotide synthesis market was valued at USD 3.18Billion in 2023.
The oligonucleotide synthesis market key players include Thermo Fisher Scientific, Merck KGaA, LGC Limited, Maravai Life Sciences, Alnylam Pharmaceuticals, Inc., Biogen Inc., Danaher Corporation, Eurofins Scientific, Ionis Pharmaceuticals, Inc., Kaneka Corporation.
Over the past few years, the market has seen a growth in demand for high quality synthesized oligonucleotides due to research institutes and diagnostic centers turning their attention to genomics and genetics. Antisense oligonucleotides were used as part of a novel therapy strategy developed by rosalind franklin university of medicine and science researchers to treat the neurological disease Batten disease, which is lethal in children, these elements are anticipated to fuel the growth of the worldwide oligonucleotide synthesis market.
The global oligonucleotide synthesis market is divided into product, application, end user, and region.
The oligonucleotide synthesis market’s largest regional section is North America, which consists of the US and Canada. The market for oligonucleotide synthesis was dominated by the North American region in 2022.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.